GRFS Price Targets and Analyst Ratings NASDAQ:GRFS
GRFS Forecast. What You Should Know.
GRFS Historical Ratings and Targets
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solutions to treat patients with chronic, rare, prevalent, and life-threatening diseases. It offers immunogl... Read more
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.